The Aluminium Federation (ALFED), in partnership with innovation funding experts Leyton, is proud to release the second instalment of our monthly R&D series, aimed at helping UK businesses unlock the full value of R&D tax relief.
This month, we delve into “Qualifying Cost Categories”, an essential guide for life sciences and advanced manufacturing companies seeking to maximise their R&D tax claims. By understanding which expenses qualify and how to document them effectively, businesses can significantly enhance the value of their claims, fuelling future innovation and growth.
Key Highlights from Episode 2:
- Employee Staffing Costs
Salaries, employer contributions (NICs and pensions), bonuses, and even reimbursed travel for staff directly involved in R&D may all be eligible. Proper time tracking and apportionment between R&D and non-R&D tasks are crucial. - Consumables
Materials such as chemicals, reagents, and lab prototypes used or discarded during R&D activities are eligible—so long as they are consumed or irreversibly altered in the process. - Subcontractor Costs
Third-party expertise is common in solving technical uncertainties. Payments to qualifying subcontractors conducting R&D work may be claimable, with UK-based requirements coming into effect from April 2024. - Externally Provided Workers (EPWs)
Agency or contract staff can be included in your claim if they’re working under the same conditions as employees and are directly involved in R&D. - Software Licenses
Specialist software tools used for simulations, modelling, or data analysis qualify—if used specifically for R&D purposes. - Data Licenses and Cloud Computing Services
As data becomes integral to innovation, associated cloud and license costs can be claimed, with a focus on correct apportionment when used across different functions.
Why It Matters
By properly identifying and categorising these costs, companies can maximise the return on their R&D investments. Whether you’re pioneering new therapies, enhancing medical technologies, or solving technical challenges, a strategic approach to R&D tax relief can provide a vital funding stream.
Stay Tuned
The ALFED x Leyton R&D series continues next month with Episode 3, where we will explore the upcoming changes to merged R&D tax relief schemes.
For more information, contact:
???? partner@leyton.com
???? 020 4525 0879
